FOXD1 Repression Potentiates Radiation Effectiveness by Downregulating G3BP2 Expression and Promoting the Activation of TXNIP-Related Pathways in Oral Cancer. This evidence concerns the gene FOXD1 and lip and oral cavity carcinoma.